## HON: Honeywell International Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 0.6% below STRENGTH zone (4.0-10.0%); PEG 1.84 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($189.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 3)

**1. Honeywell warns of $470M charge as portfolio reshaping continues (HON:NASDAQ)**
- Source: Seeking Alpha | 20251222T192544 | Somewhat-Bearish | Relevance: 100%
- Honeywell International has updated its Q4 outlook, announcing a $470 million legal charge linked to ongoing litigation with Flexjet. This charge will impact GAAP earnings, reducing EPS by about $0.47, though it is excluded from adjusted non-GAAP results. The company is actively reshaping its portfolio, including the spin-off of its Advanced Materials business and plans for further divestitures, which entail execution risks.

**2. Honeywell Stock Is Sliding Premarket Today – Two Moves Are Driving This Drop**
- Source: Stocktwits | 20251222T115452 | Bearish | Relevance: 100%
- Honeywell International Inc. (HON) shares fell almost 3% in premarket trading after the company lowered its full-year 2025 adjusted sales and earnings outlook. The revised forecast follows the reclassification of its Advanced Materials business as discontinued operations and a significant charge related to Flexjet-related litigation.

**3. Honeywell says it has a $470 million Flexjet problem, and a lowered profit outlook**
- Source: MarketWatch | 20251222T074400 | Bearish | Relevance: 100%
- Honeywell International is facing a $470 million one-time cash settlement payment related to a Flexjet lawsuit, causing its stock to fall and leading to a lowered full-year earnings outlook. The company also reclassified its advanced-materials business as "discontinued operations" following the spinoff of Solstice Advanced Materials.

**4. Will Indra Nooyi’s Board Appointment and Portfolio Shake-Up Change Honeywell International's (HON) Narrative?**
- Source: Simply Wall Street | 20251220T020827 | Neutral | Relevance: 100%
- Honeywell International announced former PepsiCo CEO Indra Nooyi will join its board, bringing extensive experience as the company prepares for major business separations. This appointment aims to strengthen oversight during a complex portfolio reshaping, following the spin-off of its Advanced Materials business and planned separations of Aerospace and Automation. While the breakup is intended to unlock value, investors should consider potential execution risks and one-time separation costs.

**5. Honeywell International (NASDAQ:HON) Updates FY 2025 Earnings Guidance**
- Source: MarketBeat | 20251222T120900 | Somewhat-Bearish | Relevance: 100%
- Honeywell International (NASDAQ:HON) has updated its FY 2025 earnings guidance, lowering its EPS outlook to $9.70-$9.80 and revenue to $37.5B-$37.7B, both below consensus estimates. Despite this, the company announced a dividend increase to $1.19 per quarter. Analyst reactions are mixed, with a consensus "Hold" rating and an average price target of $236.56.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Evercore ISI Gr | $255 | $0 | 0% |
| 2025-12-04 | Barclays | $269 | $270 | -0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Evercore ISI Gr | init | Outperform |
| 2025-12-04 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 6 ($0.12M) |
| Sells | 5 ($0.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (-0.3%)
- Blackrock Inc.: 7.1% (+6.1%)
- State Street Corpora: 4.4% (-0.8%)
- JPMORGAN CHASE & CO: 3.0% (+112.5%)
- Morgan Stanley: 2.7% (+0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.84 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 35%, margin 15%). Balance sheet: $2.9B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $132.1B |
| Beta | 0.95 |
| 52W Range | $169.05 - $227.82 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.84 |
| Forward P/E | 18.5 |
| Current P/E | 18.4 |
| YoY Growth | -0.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.4% to 0.6% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.4pp (needs >4.0% for momentum thesis). MRS_5 (-2.5%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.97x), long-term trend not supportive. MACD histogram positive (0.79), confirming momentum. RSI neutral at 52. Elevated volume (1.3x 20MA), institutional activity likely. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.60% (CS: 52) | Neutral |
| RSI_14 | 51.8 | Neutral |
| MACD Histogram | 0.79 | Bullish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 1.003x | Above |
| vs SMA200 | 0.969x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $195.96
- **Stop Loss:** $189.22 (3.4% risk)
- **Target:** $202.70 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 133
- **Position Value:** $26,062.68
- **Portfolio %:** 26.06%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-05 (Est: $2.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.57 | $2.82 | +9.9% |
| 2025Q2 | $2.66 | $2.75 | +3.4% |
| 2025Q1 | $2.21 | $2.51 | +13.6% |
| 2024Q4 | $2.35 | $2.47 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*